Katherine Wood

Katherine Wood is a Partner with TPG Capital based San Francisco, where she focuses on investments in the healthcare sector. She currently serves on the Boards of LifeStance Health, Convey Health Solutions, Kadiant, Ellodi Pharmaceuticals and Neogene Therapeutics, and was previously on the Boards of Adare Pharmaceuticals and AskBio. She was involved in TPG’s investments in […]

Todd Sisitsky

Todd Sisitsky is the President of TPG and Co-Managing Partner of TPG Capital. He also co-leads TPG Capital’s healthcare group and its investment activities in the healthcare services, pharmaceutical, and medical device sectors. Todd has played leadership roles in TPG’s investments in Adare Pharmaceuticals, Allogene Therapeutics, Aptalis, Biomet, Ellodi Pharmaceuticals, Exactech, Fenwal, Healthscope, IASIS Healthcare, […]

Troy Hamilton

Troy Hamilton has more than 25 years of experience in the biopharmaceutical and healthcare industries. Previously, he was the Global Head of Specialty Pharma at Adare Pharmaceuticals. He has held several executive and global commercial leadership roles at Synergy Pharmaceuticals, Shire Pharmaceuticals, and Johnson & Johnson’s Janssen Pharmaceuticals and McNeil Specialty Products. Troy has significant […]

John Fraher

John Fraher is the CEO of Adare Pharma Solutions. He has more than 30 years of experience in the pharmaceutical and life science industries. Previously, he was President of Aptalis Pharmaceutical Technologies. Prior to Aptalis, he held a number of executive positions at Eurand, including CEO, President, and Chief Commercial Officer. Mr. Fraher also held […]

John Schilling, M.D.

John Schilling, M.D. leads the Operations team for TPG Capital, where he also co-leads the platform’s healthcare team. He has played leadership roles on TPG’s investments in Adare Pharmaceuticals, Aptalis, BVI, EnvisionRx, Immucor, and Par Pharmaceutical. Prior to joining TPG in 2011, Dr. Schilling managed sales and marketing for the U.S. pharmaceutical business at Abbott […]